UBS (Lux) Strategy Fund - Equity (CHF) P-acc

Reference Data

ISIN LU0071007289
Valor Number 529255
Bloomberg Global ID SBCCWEC LX
Fund Name UBS (Lux) Strategy Fund - Equity (CHF) P-acc
Fund Provider UBS Asset Management Switzerland AG, Zurich 8098 Zürich, Schweiz
E-Mail: ubs-am-wholesale-switzerland@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS Global Asset Management
Basel
Phone: +41 61 288 20 20
Asset Class Asset Allocation
EFC Category Equity Global Advanced Markets
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The aim of the investment policy is to participate in the growth potential of the global equity markets in a broadly diversified manner. These sub-funds invest the majority of their respective net assets globally in equities, other share-type equity interests (such as cooperative shares and dividend-right certificates), profit participation certificates, warrants on equities and equity rights, as well as other equities and equity rights which are traded on a stock exchange or other regulated market. The sub-funds may also invest globally in bonds, similar fixed-income and floating-rate securities, notes, convertible bonds, convertible notes, warrant-linked bonds and other debt securities and claims as well as warrants on debt securities and claims which are traded on a stock exchange or other regulated market.
Peculiarities

Fund Prices

Current Price * 996.95 CHF 30.10.2025
Previous Price * 997.39 CHF 29.10.2025
52 Week High * 1,001.15 CHF 27.10.2025
52 Week Low * 806.36 CHF 07.04.2025
NAV * 996.95 CHF 30.10.2025
Issue Price * 996.95 CHF 30.10.2025
Redemption Price * 996.95 CHF 30.10.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 328,708,424
Unit/Share Assets *** 309,335,360
Trading Information SIX

Performance

YTD Performance +9.62% 31.12.2024
30.10.2025
1 month +2.49% 30.09.2025
30.10.2025
3 months +4.39% 30.07.2025
30.10.2025
6 months +11.92% 30.04.2025
30.10.2025
1 year +8.69% 30.10.2024
30.10.2025
2 years +29.52% 30.10.2023
30.10.2025
3 years +26.43% 31.10.2022
30.10.2025
5 years +34.06% 30.10.2020
30.10.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI 74.87
ADDI Date 30.10.2025

Top 10 Holdings ***

UBS MSCI ACWI Universal ETF USD dis 18.50%
UBS (Lux) ES Enga for Imp(USD) UX Acc 10.41%
UBS (Lux) ES Glb Gr sust ($) U-X acc 7.03%
UBS (Lux) EF Global Imp(USD)U-X-acc 5.86%
Novartis AG Registered Shares 4.84%
UBS (Lux) ES Active Clmt Awr USD I-X 4.69%
UBS (Lux) ES L/T Thms $ USD U-X-acc 4.65%
UBS (Lux) ES Global Hi Div $ I-X-acc 4.61%
Nestle SA 4.59%
Roche Holding AG 4.30%
Last data update 31.08.2025

Cost / Risk

TER 2.01%
TER date 31.01.2025
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 1.54%
Ongoing Charges *** 2.01%
SRRI ***
SRRI date *** 30.09.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)